STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands	Total	Preferred stock Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity
Beginning balance (in shares)			17,887,631
Beginning balance at Dec. 31, 2020		$ 156,433
Beginning balance (in shares) at Dec. 31, 2020		13,752,043
Increase (Decrease) in Temporary Equity
Issuance of Series E preferred stock, net of issuance costs		$ 4,944
Issuance of Series E preferred stock, net of issuance costs (in shares)		254,886
Ending balance at Mar. 31, 2021		$ 161,377
Ending balance (in shares) at Mar. 31, 2021		14,006,929
Beginning balance at Dec. 31, 2020	$ (89,428)		$ 2	$ 635	$ (90,065)	$ 0
Increase (Decrease) in Stockholders' Equity
Issuance of restricted stock (in shares)			703,425
Stock-based compensation	1,519			1,519
Issuance of shares in acquisition	368			368
Issuance of shares in acquisition (in shares)			1,010,296
Net loss	(10,962)				(10,962)
Ending balance at Mar. 31, 2021	(98,503)		$ 2	2,522	(101,027)	0
Ending balance (in shares) at Mar. 31, 2021			19,601,352
Beginning balance at Dec. 31, 2020		$ 156,433
Beginning balance (in shares) at Dec. 31, 2020		13,752,043
Ending balance at Jun. 30, 2021		$ 161,377
Ending balance (in shares) at Jun. 30, 2021		14,006,929
Beginning balance at Dec. 31, 2020	(89,428)		$ 2	635	(90,065)	0
Increase (Decrease) in Stockholders' Equity
Foreign currency translation adjustments	(11)
Unrealized gain on investments	0
Net loss	(52,160)
Ending balance at Jun. 30, 2021	(124,262)		$ 2	17,972	(142,225)	(11)
Ending balance (in shares) at Jun. 30, 2021			21,876,173
Increase (Decrease) in Stockholders' Equity
Beginning balance (in shares)			19,601,352
Beginning balance at Mar. 31, 2021		$ 161,377
Beginning balance (in shares) at Mar. 31, 2021		14,006,929
Ending balance at Jun. 30, 2021		$ 161,377
Ending balance (in shares) at Jun. 30, 2021		14,006,929
Beginning balance at Mar. 31, 2021	(98,503)		$ 2	2,522	(101,027)	0
Increase (Decrease) in Stockholders' Equity
Issuance of shares upon option exercise	69			69
Issuance of shares upon option exercise (in shares)			62,613
Stock-based compensation	1,490			1,490
Issuance of shares in acquisition	13,891			13,891
Issuance of shares in acquisition (in shares)			2,212,208
Foreign currency translation adjustments	(11)					(11)
Unrealized gain on investments	0
Net loss	(41,198)				(41,198)
Ending balance at Jun. 30, 2021	(124,262)		$ 2	17,972	(142,225)	(11)
Ending balance (in shares) at Jun. 30, 2021			21,876,173
Increase (Decrease) in Stockholders' Equity
Beginning balance (in shares)			21,876,173
Beginning balance (in shares)			92,648,036
Beginning balance at Dec. 31, 2021		$ 0
Beginning balance (in shares) at Dec. 31, 2021		0
Ending balance at Mar. 31, 2022		$ 0
Ending balance (in shares) at Mar. 31, 2022		0
Beginning balance at Dec. 31, 2021	366,107		$ 9	557,136	(191,025)	(13)
Increase (Decrease) in Stockholders' Equity
Issuance of shares upon option exercise	213			213
Issuance of shares upon option exercise (in shares)			187,151
Stock-based compensation	3,680			3,680
Foreign currency translation adjustments	(10)					(10)
Net loss	(29,494)				(29,494)
Ending balance at Mar. 31, 2022	340,496		$ 9	561,029	(220,519)	(23)
Ending balance (in shares) at Mar. 31, 2022			92,835,187
Beginning balance at Dec. 31, 2021		$ 0
Beginning balance (in shares) at Dec. 31, 2021		0
Ending balance at Jun. 30, 2022		$ 0
Ending balance (in shares) at Jun. 30, 2022		0
Beginning balance at Dec. 31, 2021	366,107		$ 9	557,136	(191,025)	(13)
Increase (Decrease) in Stockholders' Equity
Foreign currency translation adjustments	(50)
Unrealized gain on investments	2
Net loss	(58,174)
Ending balance at Jun. 30, 2022	316,193		$ 9	565,444	(249,199)	(61)
Ending balance (in shares) at Jun. 30, 2022			92,780,988
Increase (Decrease) in Stockholders' Equity
Beginning balance (in shares)			92,835,187
Beginning balance at Mar. 31, 2022		$ 0
Beginning balance (in shares) at Mar. 31, 2022		0
Ending balance at Jun. 30, 2022		$ 0
Ending balance (in shares) at Jun. 30, 2022		0
Beginning balance at Mar. 31, 2022	340,496		$ 9	561,029	(220,519)	(23)
Increase (Decrease) in Stockholders' Equity
Issuance of shares upon option exercise	215			215
Issuance of shares upon option exercise (in shares)			195,418
Repurchase of common stock (in shares)			(249,618)
Stock-based compensation	4,200			4,200
Foreign currency translation adjustments	(40)					(40)
Unrealized gain on investments	2					2
Other (in shares)			1
Net loss	(28,680)				(28,680)
Ending balance at Jun. 30, 2022	$ 316,193		$ 9	$ 565,444	$ (249,199)	$ (61)
Ending balance (in shares) at Jun. 30, 2022			92,780,988
Increase (Decrease) in Stockholders' Equity
Beginning balance (in shares)			92,780,988